• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

vision loss

black and white art of eyes
Marketing

Tenpoint names commercial chief ahead of vision drug launch

As chief commercial officer, Carol Kearney will oversee preparations to launch a rival to AbbVie’s age-related blurry near vision product Vuity.
Nick Paul Taylor Mar 11, 2025 1:01pm
Eye eye anatomy eye disease vision disorder ophthalmology

Neurotech nabs first nod for eye disease cell therapy implant

Mar 10, 2025 9:50am
A graphic from Ora and BlindCANs work on The Blind Canvas Project in collaboration with the Academy of Music for the Blind

CRO Ora showcases key role music plays in the blind community

Dec 12, 2024 10:35am
iris eye eyeball eye art

Genentech, ADA launch new 'eye pledge'

Oct 31, 2023 10:00am
People on a beach with an eye-shaped portal

Roche opens up the world with new ad for Vabysmo

Apr 25, 2023 4:50pm
eye eyeball retinal diseases

Vision loss cell therapy implant hits primary goals in phase 3

Nov 8, 2022 7:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings